193 related articles for article (PubMed ID: 27429508)
1. Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Jakubowska K; Pryczynicz A; Januszewska J; Sidorkiewicz I; Kemona A; Niewiński A; Lewczuk Ł; Kędra B; Guzińska-Ustymowicz K
Dis Markers; 2016; 2016():9895721. PubMed ID: 27429508
[TBL] [Abstract][Full Text] [Related]
2. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
[TBL] [Abstract][Full Text] [Related]
3. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
Juuti A; Lundin J; Nordling S; Louhimo J; Haglund C
Oncology; 2006; 71(1-2):61-8. PubMed ID: 17377415
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.
Pryczynicz A; Guzińska-Ustymowicz K; Dymicka-Piekarska V; Czyzewska J; Kemona A
Folia Histochem Cytobiol; 2007; 45(1):37-40. PubMed ID: 17378244
[TBL] [Abstract][Full Text] [Related]
7. Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer.
Xiang T; Xia X; Yan W
Am J Ther; 2017; 24(4):e431-e434. PubMed ID: 26866436
[TBL] [Abstract][Full Text] [Related]
8. Annexin A2 and CD105 expression in pancreatic ductal adenocarcinoma is associated with tumor recurrence and prognosis.
Huang YK; Liu H; Wang XZ; Zhu S
Asian Pac J Cancer Prev; 2014; 15(22):9921-6. PubMed ID: 25520129
[TBL] [Abstract][Full Text] [Related]
9. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
11. [The role of matrix metalloproteinases in pancreatic ductal adenocarcinoma].
Tsyganov SE; Paklina OV; Setdikova GR; Shabunin AV; Bedin VV; Tavobilov MM; Nikitin PN
Arkh Patol; 2012; 74(1):16-8. PubMed ID: 22712298
[TBL] [Abstract][Full Text] [Related]
12. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
13. High-Level Expression and Prognostic Significance of Matrix Metalloprotease-19 and Matrix Metalloprotease-20 in Human Pancreatic Ductal Adenocarcinoma.
Zhai LL; Wu Y; Cai CY; Huang Q; Tang ZG
Pancreas; 2016 Aug; 45(7):1067-72. PubMed ID: 26692439
[TBL] [Abstract][Full Text] [Related]
14. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor.
Ito T; Ito M; Shiozawa J; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1999 Jul; 12(7):669-74. PubMed ID: 10430270
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
16. Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.
Zhou L; Yu L; Ding G; Chen W; Zheng S; Cao L
Pathol Oncol Res; 2015 Sep; 21(4):1141-7. PubMed ID: 25986715
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase 2 and 9 activity in the development of pancreatic cancer.
Durlik M; Gardian K
Pol Przegl Chir; 2012 Aug; 84(8):377-82. PubMed ID: 22985699
[TBL] [Abstract][Full Text] [Related]
18. Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models.
Ricci C; Mota C; Moscato S; D'Alessandro D; Ugel S; Sartoris S; Bronte V; Boggi U; Campani D; Funel N; Moroni L; Danti S
Biomatter; 2014; 4():e955386. PubMed ID: 25482337
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Zhang X; Lu J; Zhou L; You L; Liang Z; Guo J; Zhao Y
Pancreas; 2020 Jul; 49(6):812-821. PubMed ID: 32590618
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Ranogajec I; Jakić-Razumović J; Puzović V; Gabrilovac J
Med Oncol; 2012 Jun; 29(2):561-9. PubMed ID: 21611838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
